From: Paul H. Christiansen | 6/15/2023 12:13:08 PM | | | | Big Impinj Bet by Fidelity
Impinj (PI) - Institutional Investor Ownership Changes | Source: UV Metrics.com | | Previous Position | New Position | Date | Institution | Shares | Shares | % Owned | % Change | 12-Jun-23 | Fidelity | 519,287 | 2,815,362 | 10.6% | 442.2% | |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
From: Paul H. Christiansen | 6/15/2023 12:14:33 PM | | | | Impinj (PI) Quarterly Revenue Chart | Data Source: UV Metrics.com | FY | | Report Date | Forecast | Forecast vs Actual | Actual | Actual Y/Y Change | Actual Y/Y vs Forecast Change | 2021 | Q1 | | | | 45,248 | | | Q2 | | | | 47,268 | | | Q3 | | | | 45,193 | | | Q4 | 9-Feb-22 | | | 52,574 | | | 2022 | Q1 | 27-Apr-22 | 51,000 | 12.7% | 53,144 | 17.5% | 4.7% | Q2 | 27-Jul-22 | 55,000 | 16.4% | 59,796 | 26.5% | 10.1% | Q3 | 26-Oct-22 | 64,500 | 42.7% | 68,270 | 51.1% | 8.3% | Q4 | 8-Feb-23 | 72,500 | 37.9% | 76,590 | 45.7% | 7.8% | 2023 | Q1 | 26-Apr-23 | 83,500 | 57.1% | 85,897 | 61.6% | 4.5% | | Q2 | | 85,500 | | | | | | Q3 | | | | | | | | Q4 | | | | | | | |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
From: Paul H. Christiansen | 7/10/2023 4:33:22 PM | | | | Interesting Fidelity BIG BET
10X Genomics (TXG) - Institutional Investor Ownership Changes
| Source: UV Metrics.com
|
| Previous Position
| New Position
| Date
| Institution
| Shares
| Shares
| % Owned
| % Change
| 10-Jul-23
| Fidelity
| 4,372,294
| 13,047,330
| 12.7%
| 198.4%
| |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
From: Paul H. Christiansen | 7/28/2023 11:56:46 AM | | | | PROCEPT BioRobotics (PRCT) -
2023-07-28 PROCEPT BioRobotics (PRCT) Research
According to most recent Investor Presentation, PRCT estimates TAM equals $20 Billion.
The latest 10-quarterly revenues total $166,996, which represents less than 1% of TAM.
Fidelity owns 14.6% of PRCT stock. |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
From: Paul H. Christiansen | 8/7/2023 10:25:53 AM | | | | In July 10th filing, Fidelity more than tripled their investment in 10X Genomics (TXG).
10X Genomics (TXG) - Institutional Investor Ownership Changes
| Source: UV Metrics.com
|
| Previous Position
| New Position
| Date
| Institution
| Shares
| Shares
| % Owned
| % Change
| 10-Jul-23
| Fidelity
| 4,372,294
| 13,047,330
| 12.7%
| 198.4%
|
Select the following - Mastering Biology to Advance Human Health – to possibly discover the reasons for Fidelity’s BIG BET. |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
From: Paul H. Christiansen | 8/15/2023 11:09:16 AM | | | | Snippets from NVTS web site . . .
a healthy $760 million customer pipeline.
“Navitas is driving next-generation GaN technology to enable a mass-market inflection point as GaN replaces silicon for power applications including mobile fast chargers, consumer electronics, data centers, renewables and EV / eMobility.”
2022-09-13 New York Investor Meeting |
| Investing in Exponential Growth | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |